Anthony Chang, MD
banner
changucanspare.bsky.social
Anthony Chang, MD
@changucanspare.bsky.social
Prof/renal pathologist at U of Chicago; ultimate complement and bile-iever; COI - Alexion, Apellis, Novartis, Otsuka, and I never met a kidney bx I didn't like
The @nkf-professionals.bsky.social podcast for this article was released today. Had a great time discussing this topic with Osama El Shamy and Susie Hu

www.kidney.org/podcasts/kid...
Kidney Commute
www.kidney.org
September 12, 2025 at 1:08 AM
Was fun to be a part of this amazing session. Doing my best to rep the renal pathologists
August 4, 2025 at 11:46 PM
Reposted by Anthony Chang, MD
6/10
Give me something clever to say

“I think of a smoldering AMR like a slowly growing leiomyoma/uterine fibroid. We don't use chemo and using it still might not stop its growth” by @changucanspare.bsky.social
May 10, 2025 at 10:42 PM
My editorial on the importance of this study design with repeat bxs. Some questions cannot be answered otherwise.

acrjournals.onlinelibrary.wiley.com/doi/abs/10.1...
Voclosporin nephrotoxicity: a myth debunked?
Click on the article title to read more.
acrjournals.onlinelibrary.wiley.com
May 3, 2025 at 1:23 PM
Someone needs to look at a maintenance dose of complement inhibitors. I believe this is essential if we want xenotransplantation to go anywhere

#NephJC
April 30, 2025 at 1:56 AM
Yet C4d PTC deposition in ABO-incompatible transplants doesn't seem to result in bad outcomes so it's hard to wrap our heads around this complexity.

#NephJC
April 30, 2025 at 1:49 AM
Definitely possible, but then does this result in overtreatment (if/when we have good treatment)?

I think of a smoldering AMR like a slowly growing leiomyoma/uterine fibroid. We don't use chemo and using it still might not stop its growth

#NephJC
April 30, 2025 at 1:44 AM
I don't think we know. Presumably there are other non-HLA abs that also fix complement and trigger the same injury pathway
April 30, 2025 at 1:14 AM